Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity.

Sacha J Howell, Elizabeth Anderson, Tom Hunter, Gillian Farnie, Robert B Clarke

    Research output: Contribution to journal › Article › peer-review

    57 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity.'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science

    Immunology and Microbiology

    Biochemistry, Genetics and Molecular Biology

    Veterinary Science and Veterinary Medicine